BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37540889)

  • 1. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
    Wittek A; Steglich B; Casar C; Seiz O; Huber P; Ehlken H; Reher D; Wende S; Bedke T; Kempski J; Böttcher M; Bang C; Thingholm L; Krech T; Lohse AW; Sauter G; Rösch T; Franke A; Schramm C; Gagliani N; Pelczar P; Huber S
    Inflamm Bowel Dis; 2024 Jun; 30(6):900-910. PubMed ID: 37540889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.
    Jørgensen KK; Grzyb K; Lundin KE; Clausen OP; Aamodt G; Schrumpf E; Vatn MH; Boberg KM
    Inflamm Bowel Dis; 2012 Mar; 18(3):536-45. PubMed ID: 21456044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.
    Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH
    Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th1 and Innate Lymphoid Cells Accumulate in Primary Sclerosing Cholangitis-associated Inflammatory Bowel Disease.
    Gwela A; Siddhanathi P; Chapman RW; Travis S; Powrie F; Arancibia-Cárcamo CV; Geremia A
    J Crohns Colitis; 2017 Sep; 11(9):1124-1134. PubMed ID: 28383652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.
    Schaeffer DF; Win LL; Hafezi-Bakhtiari S; Cino M; Hirschfield GM; El-Zimaity H
    Dig Dis Sci; 2013 Sep; 58(9):2608-14. PubMed ID: 23670229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis.
    Shaw DG; Aguirre-Gamboa R; Vieira MC; Gona S; DiNardi N; Wang A; Dumaine A; Gelderloos-Arends J; Earley ZM; Meckel KR; Ciszewski C; Castillo A; Monroe K; Torres J; Shah SC; Colombel JF; Itzkowitz S; Newberry R; Cohen RD; Rubin DT; Quince C; Cobey S; Jonkers IH; Weber CR; Pekow J; Wilson PC; Barreiro LB; Jabri B
    Nat Med; 2023 Jun; 29(6):1520-1529. PubMed ID: 37322120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
    Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
    J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
    Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
    World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term oral vancomycin for refractory inflammatory bowel diseases without Clostridium difficile infection: Lessons from primary sclerosing cholangitis.
    Du W; Han W; Dong J
    Med Hypotheses; 2020 Nov; 144():110211. PubMed ID: 33254520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.